Article
NMP22 test plus cytology may hold potential for tailoring cystoscopic follow-up
TALAPRO-2: Talazoparib/enzalutamide confers significant OS benefit in mCRPC
Episode 3 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
Mevrometostat/enzalutamide combo shows rPFS benefit in mCRPC
Episode 2 Podcast: Identifying Patients with Intermediate Risk in NMIBC
Survey data highlights substantial impact of postpartum incontinence
Trends in urology: Arpeet Shah, MD, on challenges and opportunities in 2025